Glooko, a cable and mobile app that helps diabetics record their glucose readings, finally has some competition. LabStyle Innovations today announced Dario, an alternative with a key point of ...
NEW YORK, Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced the launch of a new smart blood sugar meter ...
The Dario Meter is a pocket-sized,smartphone-connected monitor for people with Type 1 and Type 2 diabetes. It's cheap and easy to use, logs blood sugar levels andother important stats via a dedicated ...
Dario, the blood glucose management app and smart meter, is now available for Android users in the UK, New Zealand. Right now, this is just the Dario Android app, but there will be a Dario ...
Israel-based DarioHealth has been granted 510(k) clearance for a version of its Blood Glucose Monitoring System that, alongside the Dario app, is compatible with iPhone 7, 8, and X, according to a ...
The Food and Drug Administration granted the Israeli digital health company DarioHealth Corp. pre-market notification 510(k) clearance for its app on certain Android smartphones. DarioHealth’s Dario ...
The Dario Diabetes Solution app was developed to help better manage type 2 diabetes. Utilizing the digital health application Dario Diabetes Solution (DDS) resulted in a significantly greater ...
CAESAREA, Israel and DANA POINT, Calif., March 11, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today revealed the world's first ...
Notably, the FDA-cleared system automatically records blood-glucose readings, eliminating the need for users to enter values each time they test their blood sugar ...
NEW YORK and CAESAREA, Israel, March 20, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), announced today the receipt of a license from Health Canada to ...
NEW YORK and CAESAREA, Israel, March 26, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that ...
Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic solution as a means to address weight and diabetes with or without a GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results